← Back to headlines
Replimune Announces Layoffs Following FDA Cancer Drug Rejection
Biopharmaceutical company Replimune plans layoffs after the U.S. Food and Drug Administration rejected its cancer drug, impacting the company's workforce and future plans.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Lionel Richie Hospitalized in ICU Following St. Louis Concert
1h ago
Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue
5h ago
Ebola Outbreak in Democratic Republic of Congo Surpasses 6,000 Cases
8h ago
England Pharmacies to Offer Free Quick Cholesterol Screening Tests
16h ago